Aug 2
|
Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline
|
Aug 2
|
Is There An Opportunity With Embecta Corp.'s (NASDAQ:EMBC) 35% Undervaluation?
|
Jul 31
|
Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock?
|
Jul 29
|
Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company
|
Jul 24
|
Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength?
|
Jul 22
|
Diabetes device firm Embecta considers sale: Financial Times
|
Jun 25
|
Embecta touts its insulin patch pump at ADA
|
Jun 24
|
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
|
Jun 22
|
Why Embecta Corp. (NASDAQ:EMBC) Could Be Worth Watching
|
May 15
|
Best Value Stocks to Buy for May 15th
|
May 13
|
Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript
|
May 10
|
Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024
|
May 10
|
Embecta Second Quarter 2024 Earnings: Beats Expectations
|
May 9
|
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
|
May 4
|
Pleasing Signs As A Number Of Insiders Buy Embecta Stock
|
May 1
|
embecta to Participate in Investor Events
|
Apr 23
|
embecta to Report Fiscal Second Quarter 2024 Financial Results
|
Mar 6
|
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
|
Feb 13
|
Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15
|
Feb 10
|
Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript
|